跳至主要内容
临床试验/NCT02342262
NCT02342262Unknown不适用

The Effects of Probiotics on the Frequency and Intensity of Migraine Attacks and Intestinal Permeability. A Placebo-controlled Trial

Wageningen University0 个研究点目标入组 80 人开始时间: 2014年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
主要终点
Frequency of migraine attacks

研究概览

简要总结

RATIONALE: The prevalence of migraine is higher in patients with various intestinal diseases. An explanation could be that migraine is caused by a 'leaky gut': an increased intestinal permeability that allows food particles to pass the gastrointestinal wall. Probiotics may be able to improve intestinal barrier function.

OBJECTIVE: To test whether probiotics, as adjuvant therapy, can reduce incidence and severity of migraine attacks by reducing intestinal permeability.

STUDY DESIGN: 12-week placebo-controlled randomized double-blind intervention with selected probiotics.

STUDY POPULATION: Adults who experience at least 4 migraine attacks per month. INTERVENTION: Subjects will receive either one daily dose of 2 g of Ecologic® Barrier or 2 grams of the placebo, containing only the carrier material (both provided by Winclove Probiotics).

MAIN STUDY PARAMETERS/ENDPOINTS: Incidence and severity of migraine attacks, measured by diaries and validated headache questionnaires will be measured at baseline and after 4, 8, and 12 weeks of probiotic/placebo administration. Secondary, intestinal permeability will be measured by the lactulose/mannitol absorption test in urine (screening, baseline and 12 weeks) and by fecal zonulin (baseline, 4, 8, and 12 weeks). Inflammation will be assessed from blood C-reactive protein and cytokine concentrations (baseline, 4, 8, and 12 weeks). Fecal samples will also be used for microbial analysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects confirm to have migraine characterized by :
  • Recurrent attacks of moderate to severe headaches, often one-sided and pounding, often with nausea and/or vomiting, aggravated by physical activity
  • Sensitivity for light or sounds is possible but not exclusive.
  • Attacks last for 4 to 72 hours.
  • Self-reported frequency of migraine attacks (or days) at least 4 per month
  • Fairly predictable/stable pattern of migraine attacks (frequency, duration, intensity)
  • Age ≥ 18 years
  • Good overall health (self-reported in medical questionnaire)

排除标准

  • Migraine patients who suffer from chronic daily migraine/headaches
  • Migraine patients who suffer from medication-dependent headaches
  • Subjects who suffer from cluster headache or tension-type headaches
  • Subjects who used antibiotics up to two months before the start of the study
  • Subjects who are unwilling to stop taking probiotics other than study products
  • Patients with a chronic use of non steroid anti inflammatory drugs (because of increased gut permeability)
  • Patients with inflammatory bowel diseases (because of increased gut permeability)
  • Pregnancy or lactation (because of their possible effect on migraine incidence)

结局指标

主要结局

Frequency of migraine attacks

时间窗: 12 weeks

次要结局

  • Inflammation markers.(12 weeks)
  • Intestinal permeability(12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

相似试验